Novartis (NVS) free cash flow

Free cash flow · fiscal 2025
$15.24B

Novartis (NVS) generated free cash flow of $15.24B in fiscal 2025 (the year ended December 31, 2025). That is 10.4% higher than the $13.81B of fiscal 2024. Figures as of 18 Nov 2026, 12:42 UTC, from Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$15.24B
Change on fiscal 2024
+10.4%
Highest on record
$15.24Bfiscal 2025
Lowest on record
$11.71Bfiscal 2023
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

Novartis free cash flow, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $15.24B in fiscal 2025 and the lowest $11.71B in fiscal 2023.

History · 4 fiscal years

Free cash flow by fiscal year

Novartis free cash flow, year by year

Novartis (NVS) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$15.24B 10.4% up
2024$13.81B 17.9% up
2023$11.71B 2.4% down
2022$12.00B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of Novartis and comparable companies
CompanyFree cash flowFiscal year
AbbVie ABBV$17.82B2025
Merck & Co MRK$12.36B2025
UnitedHealth Group UNH$16.08B2025
Novartis NVS$15.24B2025
AstraZeneca AZN$8.67B2025
Thermo Fisher Scientific TMO$6.29B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on NVS

Novartis, figure by figure

Novartis (NVS) overview: price, valuation and scorecardAll health care companies by market value

Novartis free cash flow: questions and answers

What is Novartis's free cash flow?

Novartis (NVS) generated free cash flow of $15.24B in fiscal 2025 (the year ended December 31, 2025). That is 10.4% higher than the $13.81B of fiscal 2024.

What are the highest and lowest free cash flow figures on record for Novartis?

Across the 4 fiscal years on record (2022–2025), the highest was $15.24B in fiscal 2025 and the lowest $11.71B in fiscal 2023.

How is Novartis's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Novartis it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Novartis (NVS) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/NVS/free-cash-flow

Underlying data: Yahoo Finance.